Bulk Pharmaceutical API Sources for DEXTROSE 2.5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for DEXTROSE 2.5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		66370
IS Chemical Technology		I14-6963
ABI Chem		AC1L2586
AKos Consulting & Solutions		AKOS015915125
Chembase.cn		106156
ChemMol		99098420
1717 CheMall Corporation		CA001510

Bulk Active Pharmaceutical Ingredient (API) Sources for Dextrose 2.5% in Plastic Container

Last updated: August 20, 2025

Introduction

Dextrose 2.5% Solution, primarily used in medical settings as an intravenous (IV) infusion, supplies patients with essential carbohydrates. As a critical pharmaceutical ingredient, sourcing high-quality dextrose ensures safety, efficacy, and regulatory compliance. This article evaluates the global suppliers, manufacturing standards, and market considerations for bulk dextrose suitable for infusion in plastic containers.

Understanding Dextrose 2.5% in Plastic Containers

Dextrose, chemically known as D-glucose, is a monosaccharide used extensively as an energy source in parenteral nutrition. The 2.5% concentration indicates 2.5 grams of dextrose per 100 milliliters of solution, prepared for sterile intravenous administration.

The solution's packaging—plastic containers—is chosen for convenience, safety, and sterility. Its stability, compatibility with plastics like polyvinyl chloride (PVC), and sterilization procedures influence the selection of suppliers.

Key Characteristics Required for API Suppliers

• Manufacturing Standards: cGMP compliance, FDA approval, EMA regulation.
• Source of Material: Bio-derived from corn starch or maize, with pharmaceutical-grade purity.
• Impurity Profile: Meets pharmacopoeial standards (USP, EP, JP), minimal by-products.
• Certifications: ISO, WHO GMP, and other relevant certifications.
• Supply Reliability: Scalable production capacity with consistent logistics.

Major Global API Sources for Dextrose

1. Archer Daniels Midland Company (ADM)

Overview:
ADM ranks among the world's largest producers of dextrose and glucose syrups derived from corn. Their manufacturing facilities in North America and Europe produce pharmaceutical-grade dextrose, compliant with stringent regulatory standards.

Strengths:

• Extensive global supply chain network.
• Proven track record in supplying pharma-grade APIs.
• Compliance with cGMP, FDA, and regulatory requirements.

Product Portfolio:
Offers dextrose monohydrate and anhydrous forms suitable for sterile solutions; available in bulk quantities for pharmaceutical use.

2. Cargill, Inc.

Overview:
Cargill’s pharmaceutical-grade glucose products are derived from non-GMO corn, adhering to high purity standards. Their facilities in the U.S., Europe, and Asia manufacture dextrose for parenteral nutrition.

Strengths:

• Focused on high purity, low impurity content.
• Extensive quality assurance and validation processes.
• Products compatible with plastic containers and sterilization methods.

3. Roquette Frères

Overview:
A leading European producer of pharmaceutical ingredients, Roquette supplies dextrose used in injectable fluids. Their pharmaceutical-grade produce complies with global pharmacopeias.

Strengths:

• Strong presence in Europe and Asia.
• Advanced manufacturing facilities adhering to cGMP.
• Emphasis on sustainable sourcing and quality.

4. Harbin Pharmaceutical Group (Africa, Asia)

Overview:
Harbin Pharma offers locally produced dextrose solutions tailored for regional markets, especially in Asia. Their APIs meet international standards and are often used in healthcare settings in emerging markets.

Strengths:

• Competitive pricing.
• Ability to meet regional regulatory demands.
• Capacity for large-scale supply.

5. Jowat, Inc.

Overview:
Specializes in pharmaceutical-grade glucose products, emphasizing USP, EP, and JP standards, with proven sterilization compatibility.

Strengths:

• Focused on the pharmaceutical sector.
• Robust quality management systems.
• Flexible supply arrangements for bulk API requirements.

Supply Chain & Regulatory Considerations

Ensuring API integrity from source to final application requires adherence to stringent regulatory standards. Suppliers must demonstrate cGMP compliance, validated manufacturing environments, and detailed impurity reports. Additionally, documentation such as Certificates of Analysis (CoA), Certificates of Suitability (CEPs), and batch traceability are essential.

Importantly, sourcing API suitable for IV solutions in plastic containers requires confirmation of compatibility and stability under sterilization conditions. Suppliers must provide stability data, showing that the API maintains purity and efficacy when compounded into Dextrose 2.5% solutions.

Market Trends & Considerations

The global demand for pharmaceutical-grade dextrose is anticipated to grow with the expansion of healthcare infrastructure and nutritional support therapies. Emerging markets present opportunities for supply chain diversification, but may pose challenges related to regulatory harmonization, quality standards, and infrastructure.

The ongoing emphasis on sustainable sourcing motivates suppliers to adopt environmentally friendly manufacturing practices, and traceability measures are increasingly mandated by regulators.

Quality Assurance & Certification

Selecting an API supplier involves assessing their quality assurance programs aligned with international standards:

• cGMP compliance
• ISO 9001 Certification
• Pharmacopoeial compliance (USP, EP, JP)
• Batch validation and stability data
• Traceability systems

Manufacturers should provide high-resolution Certificates of Analysis and fulfill regulatory requirements for the importing country.

Logistics & Delivery

Efficient logistics are critical, especially for temperature-sensitive API materials. The supplier must demonstrate capability to deliver bulk API in compliance with transportation regulations, ensuring the API maintains quality until dispensed into sterile sterile containers.

Conclusion

For pharmaceutical manufacturers requiring bulk dextrose API for 2.5% solutions in plastic containers, the selection of a reliable, compliant supplier is paramount. Industry leaders such as ADM, Cargill, and Roquette dominate the market with robust product portfolios, strict adherence to regulatory standards, and global supply networks. Emerging regional suppliers offer cost-effective options but demand comprehensive quality verification. Strategic sourcing, combined with rigorous quality assurance focusing on purity, stability, and regulatory compliance, ensures the integrity of the final infusion product.

---

Key Takeaways

• Top API suppliers for Dextrose 2.5% are globally recognized for their adherence to cGMP, ISO, and pharmacopoeial standards.
• Supplier selection must prioritize regulatory compliance, purity, impurity profile, and stability data.
• Logistics and cold chain management are vital for maintaining API integrity during transportation.
• Emerging regional suppliers may provide cost advantages but require thorough due diligence.
• Incorporating robust verification processes enhances safety, efficacy, and regulatory compliance of the final infusion product.

---

FAQs

1. What are the critical quality parameters for bulk dextrose API used in IV solutions?
   Key parameters include high purity (≥99%), minimal endotoxins, acceptable impurity profiles, and validated stability under sterilization conditions, complying with pharmacopeial standards like USP or EP.

2. Can APIs from non-traditional suppliers be used for pharmaceutical-grade Dextrose?
   Only if they meet stringent regulatory standards, undergo comprehensive quality testing, and are supported by detailed documentation such as Certificates of Analysis and regulatory approvals.

3. How does API compatibility with plastic containers influence sourcing decisions?
   The API must be compatible with plastic materials, resistant to leaching and degradation during sterilization, and should maintain stability within the plastic container environment.

4. What are the regulatory considerations for importing bulk dextrose API internationally?
   Importers must ensure the supplier's compliance with local regulatory authorities, provide necessary certifications, and comply with transportation, storage, and documentation requirements.

5. Are there sustainability considerations in sourcing pharmaceutical-grade dextrose APIs?
   Yes. Increasingly, suppliers emphasize sustainable sourcing, environmentally friendly manufacturing, and traceability to meet industry and regulatory expectations.

---

Sources:

[1] U.S. Pharmacopeia (USP). "Dextrose Monohydrate."
[2] European Pharmacopoeia (EP). "D-glucose."
[3] ADM Corporate Website. "Pharmaceutical-Grade Dextrose."
[4] Cargill Nutrition Inst. "High Purity Dextrose products."
[5] Roquette Official Brochure. "Pharmaceutical Dextrose Solutions."